The role of anti-PC and its subclasses and isotypes to determine the risk of future atherosclerosis and CVD ought to be determined in larger cohorts, in order to confirm and also define in more detail what role it could play as a new independent risk marker. The gene discussed is PC; the disease is atherosclerosis.